 |
acalabrutinib |
|---|---|
| Trade Name | |
| Orphan Indication | Waldenstrom macroglobulinemia |
| USA Market Approval | USA |
| USA Designation Date | 2015-10-22 00:00:00 |
| Sponsor | Acerta Pharma BV;Molenstraat 110, 5342 CC Oss; |
| |
acalabrutinib |
|---|---|
| Trade Name | |
| Orphan Indication | Waldenstrom macroglobulinemia |
| USA Market Approval | USA |
| USA Designation Date | 2015-10-22 00:00:00 |
| Sponsor | Acerta Pharma BV;Molenstraat 110, 5342 CC Oss; |